Status:
TERMINATED
Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions:
Pancreas Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Investigator proposes the development of an extended reality (xR) training platform for patients undergoing radiation treatment for pancreatic cancer. The Investigator wants to investigate the abi...
Detailed Description
Pancreatic cancer (PCa) is a devastating diagnosis with one of the lowest 5-year overall survival rates of all malignancies. It is estimated that at least 45,000 Americans will die of this disease in ...
Eligibility Criteria
Inclusion
- Men and women over 18 years of age
- Patients with a histologically confirmed diagnosis of pancreatic cancer with borderline resectable or locally advanced disease
- Receiving stereotactic body radiation therapy for pancreatic cancer with active breathing control (ABC)
- Able to read and write in English or able to understand/answer study questions and instructions with the aid of an interpreter
Exclusion
- Patients who do not provide informed consent
- Patients who chose not to answer the study questions
- Patients who chose not to use the xR device and platform
- Patients with a seizure history
Key Trial Info
Start Date :
June 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2023
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04843306
Start Date
June 3 2021
End Date
August 18 2023
Last Update
June 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States, 21231-2410